One of the main revenue-raising provisions in health reform legislation is to revise methods for calculating payments to Medicare Advantage (MA) plans.
Even if Congress fails to act, a Medicare advisory group continues to press for similar revisions in the MA payment structure. Medicare bills enacted in 2003 and 2008 made some changes to the MA rate formula, which cut MA payments by 4% to 5% for 2010. These policies have led to higher premiums for MA plans and are likely to erode participation in such plans.
Analysts have been criticizing the MA program for being more costly than the fee-for-service (FFS) program. MA payments per enrollee this year are 9% higher than for a comparable FFS beneficiary, according to the Medicare Payment Advisory Commission (MedPAC). Some of that extra money supports enhanced benefits for MA plan enrollees, which has made the program increasingly popular: nearly 11 million seniors enrolled in MA plans in 2009, and plans are available throughout most of the country.
MedPAC continues to press for "financial neutrality" between private MA plans and Medicare FFS, a recommendation it has made for the past five years. At the same time, the advisory panel supports higher payments to those plans that provide higher quality care. To promote a broader Medicare pay-for-performance approach, MedPAC seeks a system that can compare quality of care for all MA plans and FFS.
To do this, CMS needs to calculate a spectrum of clinical measures for the FFS program, along with standards for electronic health records that allow the collection of comparable patient data and quality measures. In addition, MA preferred provider organizations and PFFS plans would have to report on the same performance measures as do HMO-type plans. The aim is to create a level playing field for quality reporting and to help beneficiaries make informed choices among coverage options.
MA-PD PREMIUMS UP 14%
One result of rate cuts that have already been imposed on MA plans is a notable increase in premiums charged seniors. Private Medicare plans that offer both medical and drug benefits increased premiums 14% in 2010 on average, compared to a 5.2% increase from 2008 to 2009, according to a recent report from Avalere Health. The rate hikes are greatest for PFFS plans-up more than 30%-while HMOs are increasing premiums only 11%.
"Premiums are going up not just in the individual market but also for Medicare Advantage products," says Lindsey Spindle, Avalere vice president. In addition to dealing with Medicare rate cuts, insurers also have to contend with rising healthcare costs, as seen in Congressional action to postpone a proposed 21% cut in Medicare payments for physicians.
Jill Wechsler, a veteran reporter, has been covering Capitol Hill since 1994.
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More